What is the effect of radioiodine therapy on Helicobacter pylori infection?


Usluogullari C. A. , Onal E. D. , Ozdemir E., Caner S., ERSOY O. , ERSOY R. , et al.

TURKISH JOURNAL OF MEDICAL SCIENCES, cilt.44, ss.520-523, 2014 (SCI İndekslerine Giren Dergi) identifier identifier identifier

  • Cilt numarası: 44 Konu: 3
  • Basım Tarihi: 2014
  • Doi Numarası: 10.3906/sag-1301-142
  • Dergi Adı: TURKISH JOURNAL OF MEDICAL SCIENCES
  • Sayfa Sayısı: ss.520-523

Özet

Background/aim: Helicobacter pylori is an important human pathogen associated with gastric and duodenal ulcers, gastric mucosa-associated lymphoid tissue lymphoma, and adenocarcinoma. Radioiodine (RAI) treatment plays an important role in the management of differentiated thyroid cancer and primary hyperthyroidism. It is known that during RAI treatment, a considerable amount is absorbed by the stomach as well. In this study we aimed to reveal any therapeutic impact of RAI on H. pylori infections.